CBOE : BSEP
$0.1 (0.18%)
| Source | Headline |
|---|---|
|
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result gurufocus.com - 2026-05-30 12:00:00 |